Filing Flows › Sonoma Pharmaceuticals (SNOA) › R&D spending
Sonoma Pharmaceuticals (SNOA) R&D spending by quarter
Sonoma Pharmaceuticals' R&D spending was $597K in Q1 FY27 (first quarter fiscal 2027), +10% from Q4 FY26. Over the last 7 quarters it ranged from $411K (Q4 FY25) to $597K (Q1 FY27).
| Quarter | R&D spending | Q/Q | Y/Y |
|---|---|---|---|
| Q1 FY27 | $597K | +10% | +0.5% |
| Q4 FY26 | $545K | -2% | +33% |
| Q3 FY26 | $557K | -3% | +30% |
| Q2 FY26 | $575K | -3% | — |
| Q1 FY26 | $594K | +45% | — |
| Q4 FY25 | $411K | -4% | — |
| Q3 FY25 | $427K | — | — |
Q1 FY27 at a glance
Sonoma Pharmaceuticals, Q1 FY27: revenue $6.4M (+60% year over year), operating margin -0.6%, net loss $330K, operating cash flow −$649K. The chart follows the revenue to costs, profit and cash.
Questions
What is Sonoma Pharmaceuticals' R&D spending?
Sonoma Pharmaceuticals' R&D spending was $597K in Q1 FY27 (first quarter fiscal 2027), +10% from Q4 FY26.
How has Sonoma Pharmaceuticals' R&D spending changed?
Over the last 7 quarters it ranged from $411K (Q4 FY25) to $597K (Q1 FY27).
Q1 FY27 results → · How Sonoma Pharmaceuticals makes money →